date,title,source
Oct-19-18,Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment at the 2018 European Society for Medical Oncology (ESMO) Congress,GlobeNewswire
Nov-06-18,"Idera Pharmaceuticals (IDRA) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-06-18,Idera: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-27-18,How Many Idera Pharmaceuticals Inc (NASDAQ:IDRA) Shares Do Institutions Own?,Simply Wall St.
Dec-11-18,"United Parcel Service, Endurance International Group, Idera Pharmaceuticals, Aptevo Therapeutics, and Electro Scientific Industries  Future Expectations, Projections Moving into 2018",GlobeNewswire
Dec-12-18,"Idera Pharmaceuticals to Provide ILLUMINATE-204 Clinical Data Update on Friday, December 14, 2018",GlobeNewswire
Dec-14-18,Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment,GlobeNewswire
Dec-17-18,Today's Research Reports on Trending Tickers: Johnson & Johnson and Idera Pharmaceuticals,ACCESSWIRE
Dec-18-18,Idera Pharmaceuticals Announces Appointment of Carol A. Schafer to its Board of Directors,GlobeNewswire
Jan-04-19,Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-18-19,"How Much is Idera Pharmaceuticals, Inc.s (NASDAQ:IDRA) CEO Getting Paid?",Simply Wall St.
Feb-27-19,Idera Pharmaceuticals Completes Enrollment Into the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment,GlobeNewswire
Mar-06-19,Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Mar-07-19,"If You Had Bought Idera Pharmaceuticals Stock Five Years Ago, Youd Be Sitting On A 94% Loss, Today",Simply Wall St.
Mar-14-19,"Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year",American City Business Journals
Apr-02-19,Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting,GlobeNewswire
Apr-10-19,Idera Pharmaceuticals Provides Corporate Update,GlobeNewswire
Apr-29-19,"Need To Know: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Insiders Have Been Buying Shares",Simply Wall St.
